Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 7/20 | 0.39 |
| ▸ | GRM5 | P41594 | 3/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.36 |
| ▸ | HTR7 | P34969 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | COMT | P21964 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15576782 | 0.89 | SMN1; SMN2 (0.38) | ALDH1A1CACNA2D1 | |
| SCHEMBL12100575 | 0.87 | DRD2 (0.37) | HTR1AHTR7ALDH1A1ATM | |
| SCHEMBL12100620 | 0.83 | GAA (0.39) | DHFRALDH1A1 | |
| SCHEMBL22003272 | 0.78 | DHFR (0.43) | DHFRGRM5HTR1AHTR7HSD11B1 | |
| SCHEMBL16422195 | 0.76 | GAA (0.31) | ALDH1A1 | |
| SCHEMBL21956022 | 0.76 | HTR1A (0.51) | DHFRGRM5HTR1AHTR7 | |
| SCHEMBL16728722 | 0.74 | GAA (0.40) | ALDH1A1 | |
| SCHEMBL24180789 | 0.73 | CACNA2D1 (0.33) | CACNA2D1 | |
| SCHEMBL22788493 | 0.73 | MAPT (0.39) | HTR1AHSD11B1 | |
| SCHEMBL20201470 | 0.71 | GAA (0.46) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11600791-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3936512-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3424935-B1 | IMIDAZOPYRAZINYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-18 | — | — | US | disclosed |
| US-10873038-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-12-22 | — | — | US | disclosed |
| US-20190109287-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-11 | — | — | US | disclosed |
| EP-3424935-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-2683728-B1 | IRIDIUM COMPLEXES WITH 3-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE, 3-PHENYL-3H-IMIDAZO[4,5-b]PYRAZINE AND 1-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE CARBENE LIGANDS USED AS PHOSPHORESCENT EMITTERS IN ORGANIC LIGHT EMITTING DEVICES | UNIVERSAL DISPLAY CORP (US) | 2018-09-05 | — | — | EP | disclosed |
| US-9972793-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-15 | — | — | US | disclosed |
| US-20150021590-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-22 | — | — | US | disclosed |
| US-8883322-B2 | Pyridyl carbene phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2014-11-11 | — | — | US | disclosed |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NUDC, NCL, NDC1 | DHFR 3444/4885GRM5 3022/4885HTR1A 3860/4885 |
| US-10873038-B2 | Organic electroluminescent materials and devices | NUDC, NCL, NDC1 | DHFR 3444/4885GRM5 3022/4885HTR1A 3860/4885 |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | PAICS, PIR, NUDC | DHFR 2678/4885GRM5 3558/4885HTR1A 3104/4885 |
| US-20190109287-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NUDC, NCL, NDC1 | DHFR 3444/4885GRM5 3022/4885HTR1A 3860/4885 |
| US-11600791-B2 | Organic electroluminescent materials and devices | NUDC, NCL, NDC1 | DHFR 3444/4885GRM5 3022/4885HTR1A 3860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.